US Stock MarketDetailed Quotes

VTRS Viatris

Watchlist
  • 8.840
  • -0.120-1.34%
Close Mar 27 16:00 ET
  • 8.930
  • +0.090+1.02%
Post 19:46 ET
10.55BMarket Cap-16.68P/E (TTM)

About Viatris Company

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Company Profile

SymbolVTRS
Company NameViatris
Listing DateFeb 1, 1973
Founded2019
CEOMr. Scott A. Smith
MarketNASDAQ
Employees32000
Fiscal Year Ends12-31
AddressRobert J. Coury Global Center,1000 Mylan Boulevard
CityCanonsburg
ProvincePennsylvania
CountryUnited States of America
Zip Code15317
Phone1-724-514-1800

Company Executives

  • Name
  • Position
  • Salary
  • Scott A. Smith
  • Director and Chief Executive Officer
  • 15.93M
  • Brian Roman
  • Chief Legal Officer
  • 4.11M
  • Dr. Corinne Le Goff, Pharm.D.
  • Chief Commercial Officer
  • --
  • Theodora Mistras
  • Chief Financial Officer
  • --
  • Paul B. Campbell
  • Chief Accounting Officer and and Corporate Controller
  • --
  • Robert J. Coury
  • Chairman Emeritus
  • 41.50M
  • Melina E. Higgins
  • Chairman of the Board
  • 454.38K
  • Mark W. Parrish
  • Vice Chairman of the Board
  • 450.01K
  • Rajiv Malik
  • Director
  • 12.48M
  • JoEllen Lyons Dillon
  • Independent Director
  • 400.01K
  • Elisha W. Finney
  • Independent Director
  • 370.01K
  • Wyllie Don Cornwell
  • Independent Director
  • 370.01K
  • Richard A. Mark, C.P.A.
  • Independent Director
  • 420.01K
  • Leo Groothuis
  • Independent Director
  • 313.54K
  • James M. Kilts
  • Independent Director
  • 370.01K
  • Harry A. Korman
  • Independent Director
  • 375.01K
  • Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D.
  • Independent Director
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More